Golden Helix Inc., a leading bioinformatics solutions provider, has now announced the integration of MedGenome's OncoMD into their VarSeq software. The integration will provide VarSeq users with the [...]
AOBiome today announced three appointments to its senior management team to advance the company’s business to develop first-in-class skin health products based on Ammonia Oxidizing Bacteria (AOB). Jo [...]
Science is hard. Repeating other labs' findings is even harder. That's particularly true in the life sciences, where biologists and researchers manually run sophisticated experiments fraught with vari [...]
Amarantus BioScience has released preliminary data from a blood test for multiple sclerosis (MS) called the MSPrecise diagnostic. The company believes that the test could lead to more accurate diagnos [...]
Richard Yu, Ph.D., scientific and operations director for the QB3@953 incubator in San Francisco, told GEN his facility is also heeding the need for water conservation. “I flagged a person for using c [...]
Today, SolveBio, a provider of data infrastructure for genomics, announced a partnership with San Francisco, Calif.-based MedGenome to distribute MedGenome's OncoMD proprietary cancer mutation knowled [...]
4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license agreement with Roche to discover and de [...]
Amarantus BioScience Holdings today said that it closed on a $5 million investment from privately held mutual fund Discover Growth Fund. Amarantus plans to use the financing to further develop and com [...]
Greg Viloria of the Silicon Valley blog Nerd Stalker interviewed Kaspar Mossman, QB3 communications and marketing director, recently at QB3@953. Greg generously allowed Kaspar to explain the entire s [...]
During her internship at biotech startup Alector, Helen Lam learned for the first time the advantages that scientists gain by working in a team. She also got a career boost. Helen now works full-time [...]